Stay updated on Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Sign up to get notified when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s revision/version label was updated from v3.5.2 to v3.5.3, indicating a backend/UI version change rather than any change to the displayed trial study details.
    Difference
    0.0%
    Check dated 2026-04-24T05:46:41.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:13:11.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Difference
    0.0%
    Check dated 2026-04-02T14:49:28.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-18T22:37:42.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and v3.4.2 removed; this is a minor versioning update with no changes to study data or page behavior.
    Difference
    0.0%
    Check dated 2026-03-11T20:00:23.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Added 'Oropharynx cancer' as a related condition and a new 'Genetic and Rare Diseases Information Center' resource under Resources.
    Difference
    0.1%
    Check dated 2026-02-25T10:42:16.000Z thumbnail image

Stay in the know with updates to Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Efficacy of MEDI0457 and Durvalumab in HPV+ HNC Clinical Trial page.